Article
Quirke, Viviane;
(2014)
Targeting the American Market for Medicines, ca. 1950s–1970s: ICI and Rhône-Poulenc Compared
(/isis/citation/CBB001202354/)
Article
Greene, Jeremy A.;
(2011)
What's in a Name? Generics and the Persistence of the Pharmaceutical Brand in American Medicine
(/isis/citation/CBB001230383/)
Article
Alan Mackintosh;
(2016)
The Patent Medicines Industry in Late Georgian England: A Respectable Alternative to both Regular Medicine and Irregular Practice
(/isis/citation/CBB566583777/)
Article
Abraham, John;
Davis, Courtney;
(2006)
Testing Times: The Emergence of the Practolol Disaster and Its Challenge to British Drug Regulation in the Modern Period
(/isis/citation/CBB000770617/)
Article
Pieters, Toine;
Majerus, Benoît;
(2011)
The Introduction of Chlorpromazine in Belgium and the Netherlands (1951--1968); Tango between Old and New Treatment Features
(/isis/citation/CBB001221534/)
Article
Herzberg, David;
(2011)
Blockbusters and Controlled Substances: Miltown, Quaalude, and Consumer Demand for Drugs in Postwar America
(/isis/citation/CBB001221531/)
Article
Horwitz, Allan V.;
(2011)
Naming the Problem That Has No Name: Creating Targets for Standardized Drugs
(/isis/citation/CBB001221532/)
Article
Greene, Jeremy A.;
(2005)
Releasing the Flood Waters: Diuril and the Reshaping of Hypertension
(/isis/citation/CBB000800013/)
Article
Balz, Viola;
Hoheisel, Matthias;
(2011)
East-Side Story: The Standardisation of Psychotropic Drugs at the Charité Psychiatric Clinic, 1955--1970
(/isis/citation/CBB001221535/)
Article
Bonah, Christian;
(2013)
“The Strophanthin Question”: Early Scientific Marketing of Cardiac Drugs in Two National Markets (France and Germany, 1900--1930).
(/isis/citation/CBB001320753/)
Article
Bittencourt, Silvia Cardoso;
Caponi, Sandra;
Maluf, Sonia;
(2013)
Farmacologia no século XX: a ciência dos medicamentos a partir da análise do livro de Goodman e Gilman
(/isis/citation/CBB001420651/)
Book
Avorn, Jerry;
(2004)
Powerful Medicines: The Benefits, Risks and Costs of Prescription Drugs
(/isis/citation/CBB000830813/)
Article
Smart, Andrew;
Martin, Paul;
(2006)
The Promise of Pharmacogenetics: Assessing the Prospects for Disease and Patient Stratification
(/isis/citation/CBB000770743/)
Article
Viviane Quirke;
(2020)
Imperial Chemical Industries and Craig Jordan, “the First Tamoxifen Consultant,” 1960s–1990s
(/isis/citation/CBB851153384/)
Article
Gerald, Michael C.;
(2010)
The Rise and Fall of Celebrity Promotion of Prescription Products in Direct-to-Consumer Advertising
(/isis/citation/CBB001000205/)
Book
Hedgecoe, Adam;
(2004)
The Politics of Personalised Medicine: Pharmacogenetics in the Clinic
(/isis/citation/CBB000830804/)
Article
Harkishan Singh;
(2018)
William Brooke O'Shaughnessy (1809–1889) in India
(/isis/citation/CBB571890179/)
Article
Chen, Lijuan;
Wang, Chuanchao;
(2012)
The Great China Chemical Works Ltd. and the Manufacture of Chinese Patent Medicines Using Western Technology in 1930s
(/isis/citation/CBB001252848/)
Article
Hersch Martínez, Paul;
García Poujol, Miguel;
(2008)
La flora como recurso terapéutico: el caso de los extractos fluidos de Laboratorios Codex en México
(/isis/citation/CBB000931737/)
Essay Review
Strasser, Bruno J.;
(2008)
Magic Bullets and Wonder Pills: Making Drugs and Diseases in the Twentieth
(/isis/citation/CBB001566270/)
Be the first to comment!